Evidence map›Paper›PMID 26117336›Full record

ArticleThe Journal of biological chemistry2015

Oncogenic miR-17/20a Forms a Positive Feed-forward Loop with the p53 Kinase DAPK3 to Promote Tumorigenesis.

Zhiqiang Cai, Ran Cao, Kai Zhang, Yuanchao Xue, Chen Zhang, Yu Zhou, Jie Zhou, Hui Sun, Xiang-Dong Fu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Regulatory Effects ofFood science & nutrition · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. XCHD Inhibits C6 Cell Growth Primarily via the p53/Caspase Pathway.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  11. Article
  12. miRNA Targeting: Growing beyond the Seed.Trends in genetics : TIG · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zhiqiang CaiFrom the State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China and.
Ran CaoFrom the State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China and.
Kai ZhangFrom the State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China and.
Yuanchao XueDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093-0651.
Chen ZhangFrom the State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China and.
Yu ZhouDepartment of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093-0651.
Jie ZhouFrom the State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China and.
Hui SunFrom the State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China and.
Xiang-Dong FuFrom the State Key Laboratory of Virology, College of Life Sciences, Wuhan University, Wuhan, Hubei 430072, China and Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093-0651 xdfu@ucsd.edu.
Wuhan University · CNUniversity of California, San Diego · US

Funding

FUNCTION &REGULATION OF THE HUMAN SPLICING FACTOR SC35R01GM049369 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FU, XIANG-DONG · 1993 to 2018
$7.2M
Regulation of RNA metabolism and cell growth control by SR protein kinasesR01GM052872 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOWDY, STEVEN F · 1996 to 2019
$5.4M
NIGMS NIH HHS GM049369NIGMS NIH HHS GM052872NIGMS NIH HHS R01 GM049369NIGMS NIH HHS R01 GM052872
6 · The paper itself

Abstract

MicroRNAs (miRs) are a class of small regulatory RNAs that have been implicated in diverse biological pathways, including cancer. miR-17/20a encoded by the c13orf25 locus is among the first miRs discovered to have oncogenic functions. The E2F family members have been established as the targets for these oncomiRs, which form a negative feedback loop to control cell cycle progression. However, this pathway does not seem to be sufficient to account for elevated expression of these oncomiRs in cancer cells to promote tumorigenesis. Here we report that miR-17/20a targets a p53 activating kinase DAPK3, leading to p53-dependent transcriptional de-repression of the oncomiRs. We demonstrate that DAPK3 plays a central role in preventing miR-17/20a depletion-induced genome instability and in miR-17/20a overexpression-triggered tumor formation. This newly identified tumorigenic pathway may thus contribute to miR-17/20a amplification and tumor growth in diverse human cancers.

Indexed as

Feedback, PhysiologicalGene Expression Regulation, NeoplasticAnimalsBase SequenceCarcinogenesisCell Line, TumorDeath-Associated Protein KinasesE2F1 Transcription FactorFemaleGenomic InstabilityHEK293 CellsHeLa CellsHumansMammary Glands, AnimalMammary Neoplasms, ExperimentalMiceDAPK3 protein, humanDeath-Associated Protein KinasesE2F1 protein, humanE2F1 Transcription FactorMicroRNAsMIRN17 microRNA, humanMIRN20a microRNA, humanTumor Suppressor Protein p53DNA damagemicroRNA (miRNA)oncogenep53tumor

Identifiers

PMID26117336
PMCPMC4528155
OpenAlexW1833841317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.